Life style and (preventive) health examination; personal characteristics
Characteristics persons | Margins | Periods | Smoking behaviour, 12 years or older Cigarette smokers Smoking years current cigarette smokers (number) | Smoking behaviour, 12 years or older Former cigarette smokers Smoking years former cigarette smokers (number) | Smoking behaviour, 12 years or older Former cigarette smokers Quitting years former cigarette smokers (number) | Alcohol consumption, 12 years or older Up to 1 glass per day in the population (%) | Alcohol consumption, 12 years or older Guideline alcohol use (%) | Drugs use, 12 years or older Use of cannabis Last year (%) | Drugs use, 12 years or older Use of drugs, other than cannabis Last year (%) |
---|---|---|---|---|---|---|---|---|---|
Age: 0 to 3 years | Value | 2014 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2015 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2016 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2017 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2018 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2019 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2020 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2021 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower boundary 95% confidence interval | 2014 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower boundary 95% confidence interval | 2015 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower boundary 95% confidence interval | 2016 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower boundary 95% confidence interval | 2017 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower boundary 95% confidence interval | 2018 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower boundary 95% confidence interval | 2019 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower boundary 95% confidence interval | 2020 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower boundary 95% confidence interval | 2021 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper boundary 95% confidence interval | 2014 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper boundary 95% confidence interval | 2015 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper boundary 95% confidence interval | 2016 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper boundary 95% confidence interval | 2017 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper boundary 95% confidence interval | 2018 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper boundary 95% confidence interval | 2019 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper boundary 95% confidence interval | 2020 | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper boundary 95% confidence interval | 2021 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2014 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2015 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2016 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2017 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2018 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2019 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2020 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2021 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Lower boundary 95% confidence interval | 2014 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Lower boundary 95% confidence interval | 2015 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Lower boundary 95% confidence interval | 2016 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Lower boundary 95% confidence interval | 2017 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Lower boundary 95% confidence interval | 2018 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Lower boundary 95% confidence interval | 2019 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Lower boundary 95% confidence interval | 2020 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Lower boundary 95% confidence interval | 2021 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Upper boundary 95% confidence interval | 2014 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Upper boundary 95% confidence interval | 2015 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Upper boundary 95% confidence interval | 2016 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Upper boundary 95% confidence interval | 2017 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Upper boundary 95% confidence interval | 2018 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Upper boundary 95% confidence interval | 2019 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Upper boundary 95% confidence interval | 2020 | . | . | . | . | . | . | . |
Age: 4 to 11 years | Upper boundary 95% confidence interval | 2021 | . | . | . | . | . | . | . |
Age: 12 to 15 years | Value | 2014 | . | . | . | 92.4 | 85.4 | . | . |
Age: 12 to 15 years | Value | 2015 | . | . | . | 90.5 | 79.4 | 3.1 | 0.5 |
Age: 12 to 15 years | Value | 2016 | . | . | . | 92.0 | 82.1 | 2.7 | 1.6 |
Age: 12 to 15 years | Value | 2017 | . | . | . | 95.0 | 86.0 | 1.7 | 0.7 |
Age: 12 to 15 years | Value | 2018 | . | . | . | 93.5 | 87.1 | 1.8 | 0.4 |
Age: 12 to 15 years | Value | 2019 | . | . | . | 90.5 | 79.9 | 2.6 | 0.3 |
Age: 12 to 15 years | Value | 2020 | . | . | . | 94.9 | 86.8 | 3.7 | 0.2 |
Age: 12 to 15 years | Value | 2021 | . | . | . | 94.9 | 88.5 | 1.3 | 0.3 |
Age: 12 to 15 years | Lower boundary 95% confidence interval | 2014 | . | . | . | 90.0 | 82.1 | . | . |
Age: 12 to 15 years | Lower boundary 95% confidence interval | 2015 | . | . | . | 87.8 | 75.7 | 1.5 | 0.0 |
Age: 12 to 15 years | Lower boundary 95% confidence interval | 2016 | . | . | . | 89.4 | 78.6 | 1.2 | 0.4 |
Age: 12 to 15 years | Lower boundary 95% confidence interval | 2017 | . | . | . | 93.0 | 82.8 | 0.5 | 0.0 |
Age: 12 to 15 years | Lower boundary 95% confidence interval | 2018 | . | . | . | 91.3 | 84.1 | 0.6 | 0.0 |
Age: 12 to 15 years | Lower boundary 95% confidence interval | 2019 | . | . | . | 87.8 | 76.2 | 1.0 | 0.0 |
Age: 12 to 15 years | Lower boundary 95% confidence interval | 2020 | . | . | . | 92.7 | 83.4 | 1.8 | 0.0 |
Age: 12 to 15 years | Lower boundary 95% confidence interval | 2021 | . | . | . | 92.1 | 84.8 | 0.5 | 0.0 |
Age: 12 to 15 years | Upper boundary 95% confidence interval | 2014 | . | . | . | 94.8 | 88.6 | . | . |
Age: 12 to 15 years | Upper boundary 95% confidence interval | 2015 | . | . | . | 93.2 | 83.2 | 4.7 | 1.2 |
Age: 12 to 15 years | Upper boundary 95% confidence interval | 2016 | . | . | . | 94.5 | 85.7 | 4.1 | 2.7 |
Age: 12 to 15 years | Upper boundary 95% confidence interval | 2017 | . | . | . | 96.9 | 89.1 | 2.8 | 1.5 |
Age: 12 to 15 years | Upper boundary 95% confidence interval | 2018 | . | . | . | 95.8 | 90.2 | 3.0 | 0.9 |
Age: 12 to 15 years | Upper boundary 95% confidence interval | 2019 | . | . | . | 93.2 | 83.6 | 4.2 | 0.9 |
Age: 12 to 15 years | Upper boundary 95% confidence interval | 2020 | . | . | . | 97.1 | 90.2 | 5.6 | 0.6 |
Age: 12 to 15 years | Upper boundary 95% confidence interval | 2021 | . | . | . | 96.7 | 91.4 | 3.2 | 2.1 |
Age: 16 to 19 years | Value | 2014 | 3.0 | . | . | 36.9 | 28.6 | . | . |
Age: 16 to 19 years | Value | 2015 | 2.8 | . | . | 36.7 | 28.3 | 20.5 | 6.9 |
Age: 16 to 19 years | Value | 2016 | . | . | . | 37.9 | 30.3 | 15.1 | 7.6 |
Age: 16 to 19 years | Value | 2017 | . | . | . | 35.8 | 31.3 | 19.4 | 5.9 |
Age: 16 to 19 years | Value | 2018 | . | . | . | 44.3 | 36.0 | 17.4 | 3.7 |
Age: 16 to 19 years | Value | 2019 | . | . | . | 42.6 | 35.4 | 15.8 | 4.9 |
Age: 16 to 19 years | Value | 2020 | . | . | . | 48.6 | 39.8 | 18.9 | 7.6 |
Age: 16 to 19 years | Value | 2021 | . | . | . | 45.6 | 38.6 | 19.1 | 5.6 |
Age: 16 to 19 years | Lower boundary 95% confidence interval | 2014 | 2.6 | . | . | 32.4 | 24.4 | . | . |
Age: 16 to 19 years | Lower boundary 95% confidence interval | 2015 | 2.4 | . | . | 32.2 | 24.1 | 16.7 | 4.5 |
Age: 16 to 19 years | Lower boundary 95% confidence interval | 2016 | . | . | . | 33.3 | 26.0 | 11.7 | 5.1 |
Age: 16 to 19 years | Lower boundary 95% confidence interval | 2017 | . | . | . | 31.5 | 27.1 | 15.8 | 3.8 |
Age: 16 to 19 years | Lower boundary 95% confidence interval | 2018 | . | . | . | 39.9 | 31.7 | 14.1 | 2.0 |
Age: 16 to 19 years | Lower boundary 95% confidence interval | 2019 | . | . | . | 38.1 | 31.1 | 12.5 | 2.9 |
Age: 16 to 19 years | Lower boundary 95% confidence interval | 2020 | . | . | . | 43.8 | 35.2 | 15.2 | 5.1 |
Age: 16 to 19 years | Lower boundary 95% confidence interval | 2021 | . | . | . | 40.3 | 33.4 | 15.2 | 3.6 |
Age: 16 to 19 years | Upper boundary 95% confidence interval | 2014 | 3.3 | . | . | 41.4 | 32.8 | . | . |
Age: 16 to 19 years | Upper boundary 95% confidence interval | 2015 | 3.1 | . | . | 41.2 | 32.5 | 24.2 | 9.3 |
Age: 16 to 19 years | Upper boundary 95% confidence interval | 2016 | . | . | . | 42.4 | 34.6 | 18.4 | 10.1 |
Age: 16 to 19 years | Upper boundary 95% confidence interval | 2017 | . | . | . | 40.1 | 35.4 | 22.9 | 8.1 |
Age: 16 to 19 years | Upper boundary 95% confidence interval | 2018 | . | . | . | 48.7 | 40.2 | 20.8 | 5.3 |
Age: 16 to 19 years | Upper boundary 95% confidence interval | 2019 | . | . | . | 47.1 | 39.7 | 19.1 | 6.9 |
Age: 16 to 19 years | Upper boundary 95% confidence interval | 2020 | . | . | . | 53.3 | 44.5 | 22.6 | 10.2 |
Age: 16 to 19 years | Upper boundary 95% confidence interval | 2021 | . | . | . | 51.0 | 44.1 | 23.7 | 8.6 |
Age: 20 to 29 years | Value | 2014 | 8.5 | 5.7 | 3.9 | 26.8 | 26.8 | . | . |
Age: 20 to 29 years | Value | 2015 | 8.1 | 5.1 | 4.1 | 25.5 | 25.5 | 18.7 | 12.3 |
Age: 20 to 29 years | Value | 2016 | 8.9 | 5.5 | 3.7 | 28.0 | 28.0 | 18.9 | 13.5 |
Age: 20 to 29 years | Value | 2017 | 8.2 | 5.4 | 3.4 | 28.6 | 28.6 | 21.6 | 15.6 |
Source: CBS. |
Table description
This table contains data on life style and on the (preventive) health examination of the Dutch population in private households. These data can be grouped by several personal characteristics.
Data available from: 2014.
Status of the data: final.
Changes by May 16, 2021
Data about physical activity (4 years or older) 2021 are added.
When will new data be published?
Data on report year 2022 will appear in March 2023.
Description topics
- Smoking behaviour, 12 years or older
- Questions on smoking behaviour are asked to persons aged 12 years or older.
- Cigarette smokers
- Smoking years current cigarette smokers
- Number of years that a current cigarette smoker of 12 years or older already has smoked.
- Former cigarette smokers
- Smoking years former cigarette smokers
- Number of years that a former cigarette smoker aged 12 years or older has smoked cigarettes.
- Quitting years former cigarette smokers
- Number of years since former cigarette smokers aged 12 years or older quitted smoking cigarettes.
- Alcohol consumption, 12 years or older
- The questions on consuming alcohol are asked to all persons aged 12 years or older.
- Up to 1 glass per day in the population
- Percentage of persons in the population aged 12 years or older who do not drink or at most 1 glass per day.
- Guideline alcohol use
- The percentage of persons in the population aged 12 years or older that meet the guideline on alcohol use. Since 2014, the guideline for persons aged 12 to 18 years is: do not drink until you are 18 years old. Since 2015, the guideline for adults is: do not drink or at most 1 glass per day. This guideline originates from the Guidelines for Good Nutrition (in Dutch: Richtlijnen Goede Voeding) of the Dutch Health Council.
- Drugs use, 12 years or older
- The questions on the use of drugs are asked to persons aged twelve years or older. For the following types of drugs, it is asked whether people have ever used it and if so, when for the last time:
Cannabis (hashish, weed, marijuana)
Amphetamine (such as pep and speed)
XTC (ecstasy, MDMA)
LSD
Mushrooms (hallucinogenic mushrooms, magic mushrooms)
Cocaine (including crack, basecoke, freebase)
Heroine (horse, smack, or brown)
GHB
Methadone
From 2018: 4-Fluoramphetamine, also known as 4-FA, 4-FMP or Flux
Other drugs
The answer categories for each type of drug are:
Yes, in the last 30 days
Yes, in the last 12 months, but not in the last 30 days
Yes, more than 12 months ago
No, never used- Use of cannabis
- Based on the question about the use of cannabis (hashish, weed, marijuana)
- Last year
- Use of drugs, other than cannabis
- Based on the question about the use of:
• Amphetamine (such as pep and speed)
• XTC (ecstasy, MDMA)
• LSD
• Mushrooms (hallucinogenic mushrooms, magic mushrooms)
• Cocaine (including crack, cooked coke, freebase)
• Heroine (horse, smack or brown)
• GHB
• Methadone
• From 2018: 4-Fluoramphetamine, also known as 4-FA, 4-FMP or Flux
• Other drugs
This concerns the use of one or more of these types of drugs. When several of these drugs are used, the most recently used drug type determines which of the answer categories ‘last month’, ‘last year’ and ‘ever’ applies.- Last year